Breaking News
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% Upgrade now

Linde trims costs, lifts margins as Praxair row brews

Stock Markets Oct 27, 2017 13:16
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Linde Group logo is seen at company's plant in Munich
 
DE30
-1.21%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
DBKGn
-1.69%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AIRP
-0.85%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
LING
0.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Georgina Prodhan and Alexander Hübner

LONDON/MUNICH (Reuters) - German industrial gases maker Linde (DE:LING) reported a 3 percent rise in third-quarter core profit, the high-end of forecasts, as a row brewed over the future of its engineering and healthcare units after a planned merger with Praxair (N:PX).

Linde and U.S. peer Praxair plan an $80 billion(£61.1 billion) all-share merger of equals to overtake France's Air Liquide (PA:AIRP) as global leader, but Praxair's higher profit margins have caused concern in Germany that Linde may be the weaker partner.

Linde's profits were lifted by cost savings but organic growth at its main gases division was just 2.6 percent, dragged down by its U.S. medical gases division, Lincare, and below Air Liquide's 4 percent and Praxair's 6 percent.

The profit margin at its gases division was 28.3 percent, compared with 32 percent for Praxair. The plant-engineering unit's margin was 9.2 percent.

Linde Chief Executive Aldo Belloni has said the engineering unit may be legally carved out after the merger but that Linde would still retain a majority.

Praxair's finance chief appeared to go further in remarks to investors last month reported by Deutsche Bank (DE:DBKGn), when he said U.S. healthcare and parts of plant engineering might not belong in the new group and there were "no sacred cows".

Praxair, outside of normal U.S. business hours, had no immediate comment on Deutsche Bank's account of CFO Matthew White's meeting with investors. White is set to become CFO of the combined group.

Linde said on Friday the two businesses would remain part of the group for the time being, and expressed irritation with White's reported comments, adding that White and Linde CFO Sven Schneider would soon meet to thrash out the matter.

"We haven't talked to Mr White but... Schneider is going to meet Mr White soon and surely we are going to challenge him about this statement in order to give him a chance to build up trust again," Belloni told a news conference.

GOOD NUMBERS

Linde's earnings before interest, tax, depreciation and amortisation (EBITDA) rose to 1.03 billion euros ($1.2 billion), versus the 1.02 billion expected on average by analysts in a Reuters poll.

Its shares rose 2.9 percent to the top of the German blue-chip DAX index (GDAXI) which was up 0.7 percent.

"Linde presented good Q3 numbers. We hope to get an update on the running (prolonged) tendering process in today's CC at 2:00 pm CET," Baader analyst Markus Mayer wrote in a note, keeping his "buy" recommendation on the stock.

Linde this week extended the acceptance period for conversion of its shares into shares of the new merged company by two weeks until Nov. 7, and lowered the minimum acceptance level to 60 percent from 75 percent.

It aims to reach 74 percent acceptance by Nov. 24, otherwise benefits for the tax inversion following the merger will not happen and the deal is likely to be called off. Belloni said on Friday 67.9 percent of shares had now been tendered.

Linde said it had secured anti-trust approval for the Praxair merger from four of the 24 necessary authorities: in Pakistan, Paraguay, Russia and Turkey, and was cooperating closely with all the other competition authorities.

Reuters reported this week that the companies were preparing to sell assets with core earnings of 650 million-750 million euros and an enterprise value of about 6.5 million-7.5 billion.

The assets up for sale have combined sales of more than 2.7 billion euros, the bulk of which are in the United States.

Linde trims costs, lifts margins as Praxair row brews
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email